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Background: The purpose of this study was to evaluate the clinical and radiographic outcomes of hip resurfacing
patients and compare them to standard primary total hip arthroplasty procedures performed during the same
period of time.
Methods: One hundred and fourteen consecutive men who had a mean age of 50 years (range, 20 to 85 years)
and who had undergone 120 hip resurfacing arthroplasties between 2007 and 2009 were compared to 117
consecutive men (120 hips) who had undergone a standard total hip arthroplasty during the same time period. The
mean follow-up was 42 months (range, 24 to 55 months) for both groups. Outcomes evaluated included implant
survivorship, hip scores, activity levels, and complication rates.
Results: In the resurfacing hip arthroplasty cohort, implant survivorship was 98% with two patients requiring a
revision surgery one for femoral neck fracture and another for femoral head loosening. In comparison, implant
survivorship was 99% in the standard total hip arthroplasty cohort, with 1 revision due to peri-prosthetic fracture
which was successfully treated with a femoral component revision. In the resurfacing and standard hip arthroplasty
cohorts, the mean post-operative Harris hip scores had improved to 96 and 94 points, respectively and were
statistically similar. The resurfacing cohort had achieved a significantly higher mean post-operative University of
California Activity Score (6.7 versus 5 points). There were no differences in the complication rates between the two
cohorts.
Conclusion: When patients meet the appropriate selection criteria in the hands of experienced and high-volume
arthroplasty surgeons, hip resurfacing provides excellent results at short- to mid-term follow-up.Background
Metal-on-metal hip resurfacing systems offer an alterna-
tive treatment to standard total hip arthroplasty in pa-
tients who have end-stage degenerative hip disease and
who have failed non-operative management [1-3]. Hip
resurfacing arthroplasty may offer greater retention of
the biomechanical characteristics of a normal hip joint,
lower dislocation rates, higher femoral bone preserva-
tion, and potentially easier revision surgeries in young
active patients who may outlive their contemporary
prosthetic device [4-6]. However, some authors believe
that many of these advantages of resurfacing hip
arthroplasty can be achieved in a standard primary total
hip arthroplasty with the use of larger femoral heads [7].* Correspondence: Mmont@lifebridgehealth.org
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reproduction in any medium, provided the orAt short- to mid-term follow-up, clinical success has
been reported to be greater than 94% of patients who
have undergone a resurfacing hip arthroplasty [8-11].
Clinical outcomes may improve when orthopaedic
surgeons move beyond their learning curves and use
narrower, more rigorous selection criteria [12,13]. With
improving hip resurfacing results, a number of studies
have compared the outcomes of standard primary
total hip arthroplasty to resurfacing hip arthroplasty
[1,14-20]. These studies have reported similar to super-
ior post-operative activity levels, functional scores, and
survival rates in the resurfacing patients. However, there
is still disagreement about whether such findings are
truly benefits of the procedure itself or reflect the higher
pre-operative activity levels in patients treated with the
resurfacing arthroplasty. Studies that can compare func-
tional results of resurfacing hip arthroplasty to standard
total hip arthroplasty across different patient populations. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Lateral frog pelvis views of a patient who underwent
a hip resurfacing arthroplasty using Cormet 2000™
(Corin, Cirencester, UK) prostheses.
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make informed and patient-based decisions regarding
their prosthesis selection [15,17-19,21-27].
Due to controversy over potential advantages or super-
iority of clinical outcomes of either of these arthroplasty
procedures, this study examined the outcomes of pa-
tients who had undergone a resurfacing hip arthroplasty
compared to all standard total hip arthroplasty proce-
dures performed during the same period of time. For
both groups, we assessed the following: (1) implant sur-
vivorship; (2) clinical outcomes; (3) activity scores; (4)
complication rates, and (5) radiographic outcomes.
Methods
A database of all consecutive patients who underwent a
resurfacing hip arthroplasty using a new resurfacing
system (Cormet 2000™, Corin, Cirencester, United
Kingdom) (Figure 1 and 2) between November of 2007
and September of 2009 was reviewed. All procedures
were performed at a single high-volume institution by
an experienced fellowship trained adult reconstructive
surgeon (MAM) who had performed over 1,000 prior re-
surfacing arthroplasty procedures using a different type
of hip resurfacing system. The senior author switched toFigure 1 Antero-posterior pelvis views of a patient who
underwent a hip resurfacing arthroplasty using Cormet 2000™
(Corin, Cirencester, UK) prostheses.this new resurfacing system during November of 2007.
This report includes all consecutive patients who had re-
ceived the new resurfacing system and had a minimum
of 24 months follow-up. One hundred and thirty one pa-
tients who had undergone 137 resurfacing arthroplasties
were identified. All women were excluded from this
study (6 hips) to reduce the gender bias from the study.
One patient had been deceased due to metastatic cancer
(with an intact prosthesis) and 10 patients (10 hips) were
lost to follow-up (7%) prior to their 24-months post-
operative visit and consequently were excluded from this
study; although they had well-functioning prosthesis at
last-follow-up. The remaining patients included 114 men
(total of 120 hips) who had a mean age of 50 years
(range, 20 to 85 years) at the time of their index proced-
ure arthroplasty. All patients were evaluated both clinic-
ally and radiographically at a mean follow-up of 40
months (range, 24 to 55 months). All available medical
records, including admission history and physical exams,
pre-operative studies, post-operative reports, radio-
graphs discharge summaries, as well as office notes were
reviewed. A portion of the data from patients in the
study and comparison groups at an earlier follow-up
period has been previously published [21,28]. This study
includes all these patients at a longer follow-up period
as well as newly added consecutive patients.
Appropriate ethical approval for this study was
obtained from the Institutional Review Board at Sinai
Hospital of Baltimore for the study of these patients.
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tive cohort of men who had undergone a primary total
hip arthroplasty during the same time period by the
same surgeon. In this cohort there were 117 men who
had a mean age of 53 years (range, 14 to 89 years) and a
mean follow-up of 40 months (range, 24 to 55 months).
There were no significant differences between age, gen-
der, height, weight, body mass index, mean follow-up,
and etiology of end-stage arthritis between the two co-
horts (p= 0.09 to 0.48) (Demographic data for both
groups are summarized Table 1).
All patients in our institution receive comprehensive
pre-operative information regarding their optimal choice
for undergoing resurfacing arthroplasty versus total hip
arthroplasty. The senior author follows a narrow indica-
tion (young males who have femoral head sizes greater
than 50 millimeters) to offer resurfacing procedure to
the patients. However, the final choice is always made by
the patients. All patients who had received total hip
arthroplasty were either not an ideal patient based on
senior author’s recommendation or had refused to re-
ceive a resurfacing arthroplasty based on their personal
preferences.
All primary total hip arthroplasties were performed
through an antero-lateral approach. All patients received
an Accolade™ femoral component prosthesis (Stryker
Orthopaedics, Mahwah, New Jersey) with a Trident ™ ac-
etabular component (Stryker Orthopaedics, Mahwah,
New Jersey). The acetabular prostheses were porous-
coated and were implanted using a press-fit technique
with or without screws. The femoral prosthetic compo-
nent was a proximally porous-coated stem with a modu-
lar head, and was implanted using a press-fit technique.
All patients returned for follow-up visits at approxi-
mately six weeks, three months, six months, twelve
months, and then yearly thereafter. At each follow-up
visit, patients were examined thoroughly; clinical out-
comes were further assessed using the Harris hip scoring
system [29] and activity levels for all patients were deter-
mined a University of California Los Angeles (UCLA)Table 1 Demographics of the patients in both cohorts
Hip resurfacing coho
Number of patients 114
Number of hips 120
Gender All men
Mean age in years (range) 50 (20 to 85)
Mean body mass index in Kg/m2(range) 28.2 (19–45)
Mean follow-up in months (range) 42 (24–55)
Etiology of end-stage arthritis
Osteoarthritis 111
Osteonecrosis 9activity scores pre- and post-operatively. Patients were
also assessed for any medical or surgical complications
such as prolonged wound drainage, hematoma forma-
tion, superficial or deep infection, deep venous throm-
bosis, or pulmonary embolism.
During each post-operative visit, antero-posterior and
lateral views of the hips were obtained, and implants
were evaluated radiographically for any periprosthetic
fracture, progressive radiolucencies of the acetabular
(DeLee and Charnley zones [30] or femoral component
Gruen zones [31], implant subsidence, or component
failure.
Revisions were defined as a change of the femoral or
acetabular components for any reason including compo-
nent loosening, peri-prosthetic fracture, osteolysis, com-
ponent malalignment, or infection. Failure was defined
as revision surgery due to any septic or aseptic reasons.
Aseptic survivorship was defines as revision due to any
aseptic failure.
All data were recorded using an Excel spreadsheet
(Microsoft Corporation, Redmond, Washington) and all
statistical data analyses were performed using SPSS soft-
ware (Version 19, IBM Corporation, New York). Implant
survivorship was evaluated and compared between the
resurfacing and standard THA cohorts using Kaplan
Meier analysis and Log-ranked test statistics. Harris hip
scores and UCLA activity scores were compared using
Mann–Whitney U test. Complication rate were com-
pared using odds ratio statistics. A p-value of less than
0.05 was used as a threshold for significance.
Results
The Kaplan-Meier implant survivorship in the hip resur-
facing cohort was 98% (95% CI: 93.4 to 99.5%) at 36 and
48 months follow-up which were not significantly differ-
ent than 99% (95% CI: 94.1 to 99.9%) in the standard
total hip arthroplasty cohort (p = 0.95). In the resur-
facing cohort, two patients (n= 2 out of 120) required a
revision surgery: one for femoral neck fracture at 2






40 (24 to 58) 0.23
106
14 0.38
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arthroplasty procedure. The first patient underwent a
successful revision surgery at our institution and
achieved a Harris hip score of 92 points at 28 months
follow-up. The other patient underwent a revision sur-
gery at an outside institution and achieved Harris hip
score of greater than 80 points. In the standard total hip
arthroplasty group, there was 1 revision (n= 1 of 120)
due to a peri-prosthetic fracture after a fall approxi-
mately 2 months after the index arthroplasty procedure.
This patient was treated successfully with a femoral
component revision and achieved a Harris hip score 82
at 36 months follow-up.
There were no significant differences in mean Harris
hip scores between the hip resurfacing and patients total
hip arthroplasty cohorts (p = 0.53). The mean Harris hip
score in the hip resurfacing group improved from a
mean of 47 points (range, 31 to 62 points) pre-
operatively to a mean of 96 points (range, 72 to 100
points), post-operatively. The mean Harris hip score in
the total hip arthroplasty cohort had improved from a
mean of 41 points (range, 21 to 56 points) pre-
operatively to a mean of 94 points (range, 70 to 100
points) post-operatively which was not significantly dif-
ferent from the hip resurfacing cohort (0.22) (clinical
outcomes are summarized in Table 2).
There were significant differences in the mean post-
operative UCLA activity scores between hip resurfacing
and standard total hip arthroplasty cohorts (p=0.001).
The mean pre-operative UCLA activity scores in the re-
surfacing cohort were 3.5 points (range, 2 to 5 points)
which were significantly higher than 2.7 points (range, 1
to 4 points) in the standard THA cohort (p=0.005). Re-
surfacing patients also had achieved significantly higher
mean post-operative (6.7 vs. 5 points; p=0.001) and
mean gains in activity levels (3.1 vs. 2.3 points; p=0.002)
compared to standard THA cohort.
There were no significant differences in complication
rates between the two cohorts (p=1). In the resurfacing
hip arthroplasty cohort, one patient developed a sciatic
nerve palsy which was successfully treated with nerve
decompression surgery. This patient regained full motor
and sensory function and is doing well with achievement




Mean pre-operative Harris hip score (range) 47 (3
Mean post-operative Harris hip score in points (range) 96 (7
Pre-operative activity score in points (range) 3.6
Post-operative activity score in points (range) 6.7up. In the standard total hip arthroplasty cohort, one pa-
tient developed a wound hematoma which was success-
fully treated by drainage. This patient is doing well and
achieved a Harris hip score of 90 points at 30 months
follow-up.
Except for the patients who had undergone a revision
surgery for aseptic component failure, post-operative
radiographic evaluation and zonal analysis of the
remaining patients in both cohorts demonstrated no
progressive radiolucencies, component malalignment,
change in component position, or implant subsidence at
their most recent follow-up (Figures 1 and 2).Discussion
Metal-on-metal hip resurfacing systems offer an alterna-
tive treatment to standard total hip arthroplasty in pa-
tients who have end-stage degenerative hip disease.
Potential advantages include lower dislocation rate,
higher femoral bone preservation, and potentially easier
revision surgery in active patients who may outlive their
contemporary prosthetic device. However, there is still
disagreement about whether such findings are truly
benefits of the procedure itself or reflect on higher
pre-operative activity levels in patients treated with hip
resurfacing arthroplasty. Comparison studies between
resurfacing hip arthroplasty and standard total hip
arthroplasty can give surgeons further ability to make
patient-based decisions regarding their prosthesis selec-
tion [21]. The purpose of this study was to assess if simi-
lar clinical and radiographic outcomes were found when
modern design hip resurfacing arthroplasty was com-
pared to standard total hip arthroplasty at short- to mid-
term follow-ups.
There were a number of limitations in the present
study. This study only compared outcomes of hip resur-
facing compared to standard total hip arthroplasty in
men. Patient satisfaction and broader quality of life mea-
sures (such as SF-12 or SF-36, etc.) were also not evalu-
ated or compared between the cohorts. In addition, the
data still represent short-to mid-term outcomes in both
patient groups. Nevertheless, the authors believe that the
results are valuable since only a few studies have
compared clinical outcome and activity levels of hipl hip resurfacing Standard total hip arthroplasty P-value
98 99 0.95
0.8 0.8 1.0
1–62) 41 (21–56) 0.75
2–100) 94 (70–100) 0.9
(1–5) 2.7 (1–4) 0.001
(2–8) 5 (3–7) 0.001
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total hip arthroplasty.
Results of our study are in agreement with previous
reports showing comparable clinical results of hip resur-
facing to standard total hip arthroplasty. Pollard et al.
[13] compared clinical outcomes of a cohort of 54 resur-
facing patients (54 hips) matched to a cohort of standard
total hip arthroplasties. At a mean follow-up of 61
months (range, 51 to 71 months) and 80 months (range,
42 to 120 months), 94% and 92% survivorship was
reported in the hip resurfacing and standard total hip
arthroplasty cohorts, respectively. Mont et al. [1] com-
pared the clinical and radiographic outcomes of resur-
facing arthroplasty and standard total hip arthroplasty in
two closely matched groups of 54 patients who had a
mean age of 55 years (range 35 to 79 years). At a mean
follow-up of 40 months (range, 24 to 60 months), similar
post-operative mean Harris hip score, revision rates,
complications, pain score, and satisfaction ratings were
reported for both groups; however, the resurfacing
arthroplasty group had a significantly higher post-
operative activity score (p<0.0001). Vail et al. [10] com-
pared results of hip resurfacings in 52 patients (57 hips)
compared to a cohort of 84 patients (93 hips) in a stand-
ard hip arthroplasty cohort. At a mean follow-up of 36
months (range, 24 to 48 months), they reported a 97%
(n= 55 out of 57) and 96% (n= 89 out of 93) implant
survivorship in the resurfacing and standard hip
arthroplasty cohorts, respectively. Zywiel et al. [20] com-
pared the clinical and radiographic outcomes of resur-
facing arthroplasty and standard total hip arthroplasty in
two matched groups of 33 patients who had a mean age
of 53 years (range 37 to 79 years) and similar pre-
operative activity scores. At a mean follow-up of 42
months (range, 25 to 68 months) significantly higher
post-operative weighted activity scores were reported in
the resurfacing group (p < 0.001); however, post-
operative Harris hip score, revisions, satisfaction score,
and pain score were similar in both groups. Our results
are also in agreement with a previous report on the ex-
cellent results of Cormet 2000™ resurfacing system.
Gross et al. [7] reported results of 373 Cromet 2000™ re-
surfacing arthroplasties at a mean follow-up of 8 years
(range, 6 to 11 years). They reported a 93% implant sur-
vivorship when revision for any reason was used and
91% survivorship when radiographic failures were
included.
Conclusion
In summary, we have found a 98% implant survivorship
at a mean of 42 months follow-up for patients who had
undergone a resurfacing hip arthroplasty. Our results
suggest that metal-on-metal hip resurfacing had similar
overall outcomes when compared to standard total hiparthroplasty in terms of implant survivorship, clinical re-
sults, as well as complication rates. However, patients in
the resurfacing cohort had achieved a significantly
higher post-operative UCLA activity score. Overall, these
findings may be contributed to the combination of pa-
tient selection as well as the prosthetic design. This is
evident in higher pre-operative activity scores of the re-
surfacing group which can be attributed to patient selec-
tion, as well as, higher overall gains in activity scores in
this group which can be related to the prosthetic design.
The authors believe when patients meet the appropriate
selection criteria, in the hands of experienced and high-
volume arthroplasty surgeons, hip resurfacing provides
excellent results at short- to mid-term follow-up. Fur-
ther analysis to confirm such findings at a longer follow-
up will be necessary.
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